跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TIPIDIN TABLET 250 mg - HSA Drug Approval Details
Approvals
/
HSA
/
TIPIDIN TABLET 250 mg
Approved
THERAPEUTIC
TIPIDIN TABLET 250 mg
PT. ACTAVIS INDONESIA
🇸🇬 Health Sciences Authority
Approval Date
Sep 23, 1998
Approval ID
a44ea2969a35cdf5
Company
PT. ACTAVIS INDONESIA
Type
Therapeutic
Approval Details
Approval Id
a44ea2969a35cdf5
Drug Name
TIPIDIN TABLET 250 mg
Product Name
TIPIDIN TABLET 250 mg
Approval Number
SIN10054P
Approval Date
1998-09-23
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
B01AC05
Atc Item Name
ticlopidine
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Company Detail Path
/organization/teva-pharmaceutical-investments-singapore-pte-ltd
Active Ingredients
TICLOPIDINE HCl
250 mg/tablet
TICLOPIDINE HCl
250 mg/tablet
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 23, 1998
Approval ID
a44ea2969a35cdf5
Type
Therapeutic
Back to HSA Approvals